API Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (Websockets) API Financial News API Delisted Data API
Solutions
New & Popular APIs
Show all APIs Fundamental Data APIs Historical End-of-Day API Real-time Prices API Financial Events & News API Indices Historical Constituents API 40 000 Stock Market Logos API Forex Data APIs
Other products
Google Sheets Add-on Excel Add-on Coding Libraries (Python, R, etc) Wordpress Add-on
API Marketplace
Community
Academy 152 articles Forum Github 14 repos
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. KQ /
  3. 293780.KQ

AptaBio Therapeutics Inc (293780 KQ) stock market data APIs

₩6300 -290(-4.4%) as of November 25, 2024
Price chart is built with Anychart

AptaBio Therapeutics Inc. discovers and develops selective inhibitors of the NOX family of enzymes and aptamer-based anti-cancer drugs. The company offers Lipofector-Q, Lipofector-EXT, Lipofector-2000, Lipofector-EZ, and Lipofector-pMAX Reagent for transfecting DNA or RNA into eukaryotic cells. Its product candidates include PX-115 for treating diabetic nephropathy; APX-1004 to treat diabetic retinopathy; and APX-311 for use in treating non-alcoholic steatohepatitis (NASH). The company was founded in 2009 and is based in Yongin-Si, South Korea.

AptaBio Therapeutics Inc Financial Data Overview

6590
6300
-
6910
6300
4930-15490
145 612 M
22 299 K
2 055 M
-347.9905
1.962
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: '293780',
Type: 'Common Stock',
Name: 'AptaBio Therapeutics Inc',
Exchange: 'KQ',
CurrencyCode: 'KRW',
CurrencyName: 'Korean Won',
CurrencySymbol: '₩',
CountryName: 'Korea',
CountryISO: 'KR',
OpenFigi: 'BBG00P2BVY44',
ISIN: 'KR7293780003',
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Drug Manufacturers - Specialty & Generic',
}

AptaBio Therapeutics Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 2 055 M
  • EBITDA -17 122 765 824
  • Earnings Per Share
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get AptaBio Therapeutics Inc Earnings via APIs

  • Latest Release 2024-09-30
  • EPS/Forecast NaN

Get AptaBio Therapeutics Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get AptaBio Therapeutics Inc latest news via APIs

Aptabio to present results of Isuzinaxib Phase 2 study at The American Society of Nephrology (ASN)'s Kidney Week 2022

Aptabio's Isuzinaxib (APX-115) proves its effect on a key kidney function marker in a Phase 2 clinical study in patients with diabetes and chronic kidney disease. Isuzinaxib (APX-115) is a novel pan-...
  • AMERICAN SOCIETY OF NEPHROLOGY
  • APTABIO THERAPEUTICS
  • CHRONIC KIDNEY DISEASE
  • CLINICAL STUDY
  • DIABETIC KIDNEY DISEASE
  • DOUBLE BLIND
  • INHIBITOR
  • KIDNEY DAMAGE
  • KIDNEY FUNCTION
  • OXIDATIVE STRESS
  • PHASE 2 CLINICAL TRIAL
  • URINE ALBUMIN CREATINE RATIO
News API is available at any package from $19.99 See full price
Get sample of News API
Do you have any questions?
support@eodhistoricaldata.com